News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Israeli Drug Development Companies Are Poised For 505(b)(2) Development Process, Camargo Pharmaceutical Services Expert Says



12/17/2013 9:55:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CINCINNATI--(BUSINESS WIRE)--Many Israeli pharmaceutical executives recently learned that the 505(b)(2) development process is an important tool that can significantly reduce costs and shorten the timeline for approval of new drugs, adding substantially to ROI.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES